Upcoming EventsSee all events
Thursday, October 22, 2020
One of the backbones of the myeloma treatment regimen is lenalidomide (Revlimid). But what happens when a myeloma patient becomes resistant to this widely used oral drug? Join us for our next multiple myeloma Answers Now program on Thursday, October 22 at 2:30 pm PT/5:30 pm ET.